ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Friday, 13 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Novelix Pharmaceuticals Business Update

Novelix Pharmaceuticals entered a supply agreement with axabio NV, Belgium, to procure natural astaxanthin. No specific contract value was disclosed.

Source

BSE filing, NSE: TRIMURTHI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Novelix Pharmaceuticals Ltd: key numbers

Share price
₹69.49
Market cap
₹122.4 Cr
Revenue (annual)
₹132.3 Cr
Net profit (annual)
₹2.56 Cr
P/E (TTM)
26.3×Sector 65.7×
Promoter holding
54.29%+3.72% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Novelix Pharmaceuticals Ltd

All →

Other business update announcements

All →